Pine Valley Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
SRIM
SAM
GA
QI
AA
OFA
PM
PFS
AIP
Pine Valley Investments's NVO Position: Q2 2026 in Review
Pine Valley Investments opened a new position in Novo Nordisk (NVO) in Q2 2026: 48,469 shares worth $2.32M. The stake represents 0.09% of the portfolio and ranks #201 among its holdings. This is a return to the name: Pine Valley Investments previously reported a position in NVO as recently as Q3 2024.
Pine Valley Investments first reported a position in NVO in Q1 2024 and has held it in 4 quarters since. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Pine Valley Investments held 48,469 shares of Novo Nordisk worth $2.32M as of Q2 2026.
- Novo Nordisk was a new Pine Valley Investments position in Q2 2026.
- Novo Nordisk made up 0.09% of Pine Valley Investments's portfolio in Q2 2026, its #201 holding.
- Pine Valley Investments first reported a position in Novo Nordisk in Q1 2024 and has held it in 4 quarters since.
- 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.